Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Curr Top Microbiol Immunol ; 304: 247-68, 2006.
Article in English | MEDLINE | ID: mdl-16989274

ABSTRACT

The skin is populated with Langerhans cells, thought to be efficient, potent antigen-presenting cells, that are capable of inducing protective immunity by targeting antigen delivery to the skin. Delivery to the skin may be accomplished by active delivery such as intradermal injection, use of patches or a combination of a universal adjuvant patch with injections. The robust immunity induced by skin targeting can lead to dose sparing, novel vaccines and immune enhancement in populations with poorly responsive immune systems, such as the elderly. Vaccine delivery with patches (transcutaneous immunization), may allow self-administration, ambient temperature stabilization and ease of storage for stockpiling, leading to a new level of efficient vaccine distribution in times of crisis such as a bioterror event or pandemic influenza outbreak. The use of an adjuvant (immunostimulant) patch with injected vaccines has been shown in clinical studies to enhance the immune response to an injected vaccine. This can be used for dose sparing in pandemic influenza vaccines in critically short supply or immune enhancement for poor responders to flu vaccines such as the elderly. Transcutaneous immunization offers a unique safety profile, as adjuvants are sequestered in the skin and only delivered systemically by Langerhans cells. This results in an excellent safety profile and allows use of extremely potent adjuvants. The combination of the skin immune system, safe use of potent adjuvants and ease of delivery suggests that skin delivery of vaccines can address multiple unmet needs for mass vaccination scenarios.


Subject(s)
Mass Vaccination/methods , Vaccines/administration & dosage , Adjuvants, Immunologic , Administration, Cutaneous , Animals , Anthrax Vaccines/administration & dosage , Humans , Injections, Intradermal , Models, Animal , Skin/immunology
2.
Antimicrob Agents Chemother ; 45(12): 3555-9, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11709339

ABSTRACT

In this study, the in vitro and in vivo efficacies of free sodium stibogluconate (SSG) and a nonionic surfactant vesicular formulation of SSG (SSG-NIV) against a laboratory strain of Leishmania donovani (MHOM/ET/67:LV82) and different clinical isolates of L. donovani were determined. Treatment with SSG-NIV was more effective against intramacrophage amastigotes than treatment with SSG. In vivo murine studies showed that there was interstrain variability in the infectivity of the different L. donovani strains, with two of the strains (20001 and 20003) giving low parasite burdens. In addition, interstrain variability in the antileishmanial efficacy of SSG in a single dose containing 300 mg of Sb(V)/kg of body weight was observed. This dose of free drug either caused a >97% reduction in liver parasite burdens or had no significant effect on parasite burdens compared with the result with the respective control. In some instances, treatment with this free SSG dose also caused a significant reduction in spleen (strain 20006) or bone marrow (strains 20001 and 20009) parasite burdens. Treatment with SSG-NIV was more effective than that with SSG against all of the strains tested. In SSG-responsive strains, the reduction in liver parasite burdens by SSG-NIV treatment was similar to that caused by free SSG. In SSG-nonresponsive strains, SSG-NIV treatment caused at least a 95% reduction in liver parasite burdens. Overall, these results indicate that the use of a vesicular formulation of SSG is likely to increase its clinical efficacy against visceral leishmaniasis.


Subject(s)
Antimony Sodium Gluconate/administration & dosage , Antimony Sodium Gluconate/pharmacology , Leishmania donovani/drug effects , Leishmaniasis, Visceral/drug therapy , Schistosomicides/administration & dosage , Schistosomicides/pharmacology , Animals , Antimony Sodium Gluconate/therapeutic use , Cricetinae , Drug Carriers , Female , Leishmaniasis, Visceral/parasitology , Macrophages/drug effects , Macrophages/parasitology , Male , Mesocricetus , Mice , Mice, Inbred BALB C , Parasite Egg Count , Schistosomicides/therapeutic use , Surface-Active Agents
3.
Am J Trop Med Hyg ; 65(3): 193-6, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11561703

ABSTRACT

Kala-azar in India is becoming increasingly difficult to treat, which may be due to the presence of species other than Leishmania donovani; Leishmania tropica was reported to cause the same clinical syndrome in the area. Over the past 3 years, we have collected samples from 241 patients with visceral leishmaniasis from across the region. Of the 189 isolates that grew on diphasic medium, 159 were successfully transferred to liquid medium for typing. Clinically, 80% of these were resistant to antimony. Lipophosphoglycan-specific monoclonal antibodies were used to distinguish the 2 species by agglutination of promastigotes; all 159 were shown to be L. donovani. Eighty-three isolates were confirmed to be L. donovani by isoenzyme analysis, by amplification of kinetoplast DNA, or both, in comparison with multiple reference strains; none were L. tropica. Thus, the rising incidence of clinical resistance to treatment is unlikely to be due to a different species causing kala-azar in north Bihar.


Subject(s)
Antimony Sodium Gluconate/therapeutic use , Antiprotozoal Agents/therapeutic use , Leishmania donovani/classification , Leishmania tropica/classification , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/parasitology , Adolescent , Adult , Animals , Antibodies, Protozoan/blood , Antimony Sodium Gluconate/administration & dosage , Antiprotozoal Agents/administration & dosage , Child , DNA, Kinetoplast/chemistry , DNA, Kinetoplast/isolation & purification , DNA, Protozoan/chemistry , DNA, Protozoan/isolation & purification , Drug Resistance , Electrophoresis, Cellulose Acetate , Female , Humans , India/epidemiology , Leishmania donovani/genetics , Leishmania tropica/genetics , Male , Middle Aged , Parasitemia/drug therapy , Parasitemia/parasitology
4.
Infect Immun ; 69(8): 4884-90, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11447164

ABSTRACT

Given the emerging difficulties with malaria drug resistance and vector control, as well as the persistent lack of an effective vaccine, new malaria vaccine development strategies are needed. We used a novel methodology to synthesize and fully characterize multiple antigen peptide (MAP) conjugates containing protective epitopes from Plasmodium falciparum and evaluated their immunogenicity in four different strains of mice. A di-epitope MAP (T3-T1) containing two T-cell epitopes of liver stage antigen-1 (LSA-1), a di-epitope MAP containing T-cell epitopes from LSA-1 and from merozoite surface protein-1, and a tri-epitope MAP (T3-CS-T1) containing T3-T1 and a potent B-cell epitope from the circumsporozoite protein central repeat region were tested in this study. Mice of all four strains produced peptide-specific antibodies; however, the magnitude of the humoral response indicated strong genetic restriction between the different strains of mice. Anti-MAP antibodies recognized stage-specific proteins on the malaria parasites in an immunofluorescence assay. In addition, serum from hybrid BALB/cJ x A/J CAF1 mice that had been immunized with the tri-epitope MAP T3-CS-T1 successfully inhibited the malaria sporozoite invasion of hepatoma cells in vitro. Spleen cells from immunized mice also showed a genetically restricted cellular immune response when stimulated with the immunogen in vitro. This study indicates that well-characterized MAPs combining solid-phase synthesis and conjugation chemistries are potent immunogens and that this approach can be utilized for the development of subunit vaccines.


Subject(s)
Antigens, Protozoan/immunology , Malaria Vaccines/immunology , Malaria, Falciparum/genetics , Merozoite Surface Protein 1/immunology , Protozoan Proteins/immunology , Vaccines, Conjugate/immunology , Animals , Antibodies, Protozoan/biosynthesis , Antibodies, Protozoan/classification , Antibody Specificity , Cell Division , Cells, Cultured , Female , Interferon-gamma/analysis , Malaria, Falciparum/immunology , Malaria, Falciparum/prevention & control , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Peptides/immunology , Plasmodium falciparum/immunology , Spleen/cytology , Spleen/immunology , T-Lymphocytes/cytology , T-Lymphocytes/immunology
5.
J Infect Dis ; 181(3): 1121-8, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10720539

ABSTRACT

Leishmania infection causes marked down-regulation of interferon (IFN)-gamma-induced gene activity in macrophages, but the mechanism of the blockade has not been fully defined. The IFN-gamma signal transduction pathway was analyzed in Leishmania donovani-infected phorbol-differentiated U937 human promonocytic cells. IFN-gamma stimulation induced marked phosphorylation of its own receptor (IFN-gammaR)-alpha chain. Phosphorylation of the receptor subunit was significantly inhibited after 24 h of infection with the parasite, apparently because of decreased amounts of the receptor subunit. Formation of the IFN-gammaR complex, as assessed by tyrosine phosphorylation and association of Jak2, was strongly inhibited in cells infected for 24 h. Inhibition of the IFN-gammaR complex formation correlated with inhibition of STAT1alpha binding to the IFN-gamma response region. Pretreatment with purified parasite lipophosphoglycan before IFN-gamma stimulation had no effect on tyrosine phosphorylation. Thus, inhibition of tyrosine phosphorylation of the IFN-gammaR-alpha chain and subsequent signal transduction are most likely due to the decreased amount of IFN-gammaR-alpha protein after infection.


Subject(s)
Interferon-gamma/pharmacology , Leishmania donovani/physiology , Signal Transduction , Animals , DNA-Binding Proteins/metabolism , Glycosphingolipids/pharmacology , Humans , Phosphorylation , Receptors, Interferon/metabolism , STAT1 Transcription Factor , Trans-Activators/metabolism , Tyrosine/metabolism , U937 Cells , Interferon gamma Receptor
6.
J Immunol ; 163(8): 4481-8, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10510390

ABSTRACT

Protection from cutaneous leishmaniasis, a chronic ulcerating skin lesion affecting millions, has been achieved historically using live virulent preparations of the parasite. Killed or recombinant Ags that could be safer as vaccines generally require an adjuvant for induction of a strong Th1 response in murine models. Murine rIL-12 as an adjuvant with soluble Leishmania Ag has been shown to protect susceptible mice. We used 48 rhesus macaques to assess the safety, immunogenicity, and efficacy of a vaccine combining heat-killed Leishmania amazonensis with human rIL-12 (rhIL-12) and alum (aluminum hydroxide gel) as adjuvants. The single s.c. vaccination was found to be safe and immunogenic, although a small transient s.c. nodule developed at the site. Groups receiving rhIL-12 had an augmented in vitro Ag-specific IFN-gamma response after vaccination, as well as increased production of IgG. No increase in IL-4 or IL-10 was found in cell culture supernatants from either control or experimental groups. Delayed hypersensitivity reactions were not predictive of protection. Intradermal forehead challenge infection with 107 metacyclic L. amazonensis promastigotes at 4 wk demonstrated protective immunity in all 12 monkeys receiving 2 microgram rhIL-12 with alum and Ag. Partial efficacy was seen with lower doses of rhIL-12 and in groups lacking either adjuvant. Thus, a single dose vaccine with killed Ag using rhIL-12 and alum as adjuvants was safe and fully effective in this primate model of cutaneous leishmaniasis. This study extends the murine data to primates, and provides a basis for further human trials.


Subject(s)
Adjuvants, Immunologic/administration & dosage , Alum Compounds/administration & dosage , Interleukin-12/immunology , Leishmaniasis, Cutaneous/immunology , Leishmaniasis, Cutaneous/prevention & control , Protozoan Vaccines/immunology , Vaccines, Synthetic/immunology , Animals , Disease Models, Animal , Dose-Response Relationship, Immunologic , Humans , Immunity, Active/genetics , Interferon-gamma/metabolism , Interleukin-12/genetics , Macaca mulatta , Protozoan Vaccines/adverse effects , Protozoan Vaccines/genetics , Vaccines, Synthetic/adverse effects
7.
J Infect Dis ; 177(3): 815-8, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9498473

ABSTRACT

Cytokine mRNA levels were measured in serial splenic aspirates from 27 patients with visceral leishmaniasis during monotherapy with interferon-gamma (IFN-gamma; n = 9), sodium antimony gluconate (SAG; n = 8), or amphotericin B lipid complex (ABLC; n = 10). At baseline, mRNA for IFN-gamma was detected in 18 (86%) of 21 patients, and mRNA for interleukin (IL)-10 and IL-4 was detected in 21 (100%) and 10 (48%) of 21 patients, respectively. With IFN-gamma treatment alone, levels of IFN-gamma mRNA decreased by day 10 and then returned to baseline levels; IL-10 mRNA levels were high throughout treatment. In the SAG and ABLC groups, levels of IFN-gamma and IL-10 mRNA decreased significantly. Polarized Th2 cell type responses do not appear to develop in Indian kala-azar; instead, there is an initial mixed Th1-Th2 cell picture. With successful treatment and resolution of infection, both components of the immune response appear to involute.


Subject(s)
Cytokines/biosynthesis , Leishmaniasis, Visceral/immunology , Spleen/immunology , Adolescent , Adult , Amphotericin B/pharmacology , Antimony Sodium Gluconate/pharmacology , Drug Combinations , Humans , Interferon-gamma/biosynthesis , Interferon-gamma/pharmacology , Interleukin-10/biosynthesis , Interleukin-4/biosynthesis , Leishmaniasis, Visceral/drug therapy , Phosphatidylcholines/pharmacology , Phosphatidylglycerols/pharmacology
8.
Clin Diagn Lab Immunol ; 4(5): 530-5, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9302200

ABSTRACT

The antibody response against an amastigote-specific protein (A2) from Leishmania donovani was investigated. Sera from patients with trypanosomiasis and various forms of leishmaniasis were screened for anti-A2 antibodies. Sera from patients infected only with L. donovani or Leishmania mexicana specifically recognized the A2 recombinant protein. These results were consistent with karyotype analyses which revealed that the A2 gene is conserved in L. donovani and L. mexicana strains. The potential of this antigen in diagnosis was further explored by screening a series of sera obtained from patients in regions of the Sudan and India where L. donovani is endemic. The prevalence of anti-A2 antibodies was determined by Western blotting for all samples. Enzyme-linked immunosorbent assay (ELISA) and an immunoprecipitation assay were also performed on some of the samples. Anti-A2 antibodies were detected by ELISA in 82 and 60% of the samples from individuals with active visceral leishmaniasis (kala-azar) from the Sudan and India, respectively, while the immunoprecipitation assay detected the antibodies in 92% of the samples from India. These data suggest that the A2 protein may be a useful diagnostic antigen for visceral leishmaniasis.


Subject(s)
Antibodies, Protozoan/analysis , Leishmania donovani/immunology , Leishmaniasis, Visceral/immunology , Protozoan Proteins/immunology , Animals , Antigen-Antibody Reactions , Antigens, Protozoan/analysis , Blotting, Western , Enzyme-Linked Immunosorbent Assay , Glutathione Transferase/genetics , Humans , Karyotyping , Leishmania donovani/genetics , Leishmania mexicana/genetics , Leishmania mexicana/immunology , Leishmaniasis, Visceral/diagnosis , Precipitin Tests , Protozoan Proteins/genetics , Recombinant Fusion Proteins/immunology , Serologic Tests
9.
Clin Infect Dis ; 23(5): 1007-11, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8922794

ABSTRACT

Exposure of expatriates to the infective larvae of Wuchereria bancrofti can result in the early development of signs of lymphatic obstruction. The findings on the clinical presentation of expatriates are distinct from the chronic pathological findings seen among the native population and are similar to the findings in experimentally infected persons. We report the case of a Peace Corps volunteer who developed acute lymphatic dysfunction within 3 months of arriving in an area that was endemic for filariasis. The diagnosis was established clinically and by demonstrating the presence of antibodies to recombinant proteins specific for patients with lymphatic filariasis. Lymphatic flow was markedly abnormal when assessed with use of 99mTc-lymphoscintigraphy. Treatment with diethylcarbamazine reversed both the physical and lymphoscintigraphic abnormalities.


Subject(s)
Diethylcarbamazine/therapeutic use , Elephantiasis, Filarial/drug therapy , Wuchereria bancrofti/isolation & purification , Adult , Animals , Antibodies, Helminth/analysis , Elephantiasis, Filarial/diagnostic imaging , Elephantiasis, Filarial/immunology , Elephantiasis, Filarial/physiopathology , Humans , Magnetic Resonance Imaging , Radionuclide Imaging , Wuchereria bancrofti/immunology
10.
Mol Biochem Parasitol ; 81(1): 27-40, 1996 Oct 18.
Article in English | MEDLINE | ID: mdl-8892303

ABSTRACT

Genome plasticity has been hypothesized to be a driving force behind parasite speciation. We have evaluated divergence in single and low-copy genes in terms of locus organization, chromosomal localization and gene expression in Leishmania infantum, L. major, L. tropica and three widely divergent geographic isolates of L. donovani. Seventeen genes of low to moderate copy number (1-4 copies/haploid genome) were analyzed to identify restriction fragment length polymorphisms (RFLPs) providing heritable markers distinguishing Old World (OW) leishmanias. These RFLP markers were conserved in parasite isolates from primary infections demonstrating their utility as diagnostic tools. The species designations established by RFLP analysis of field isolates was confirmed by use of monoclonal antibodies. All 17 genes were present in each OW leishmania analyzed except LSIP (A45), which was absent from L. infantum. The 17 genes were found to be distributed among 9 distinct chromosomes. However, in spite of variations in chromosome karyotypes among the various OW leishmanias, individual gene probes localized to a similar sized chromosome from each isolate. These observations coupled with a molecular tree derived from RFLP data suggest that the OW leishmanias comprise a monophyletic lineage, with species associated with cutaneous disease exhibiting the greatest level of divergence. Data from this study supports previous observations that species causing cutaneous and visceral disease have diverged primarily by nucleotide substitutions. Such nucleotide divergence may not only lead to changes in protein function and antigenicity, but may also alter gene regulation programs as exemplified by the finding that the LdI-9-5 and LdE-6-1 genes were expressed only in visceralizing leishmanias.


Subject(s)
Genes, Protozoan , Leishmania/genetics , Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/parasitology , Animals , Antibodies, Monoclonal , Base Sequence , Conserved Sequence , DNA, Protozoan/genetics , Evolution, Molecular , Genetic Markers , Genetic Variation , Leishmania/immunology , Leishmania/isolation & purification , Leishmania donovani/genetics , Leishmania infantum/genetics , Leishmania major/genetics , Leishmania tropica/genetics , Molecular Sequence Data , Multigene Family , Polymorphism, Restriction Fragment Length , Species Specificity
11.
Blood ; 88(5): 1841-5, 1996 Sep 01.
Article in English | MEDLINE | ID: mdl-8781442

ABSTRACT

The cytosolic 67-kD protein in phagocytes (p67-phox) and B lymphocytes is one of essential components of the superoxide-generating system in these cells, and its defect causes an autosomal recessive type of chronic granulomatous disease (CGD). We performed mutation analysis of p67-phox mRNA from a CGD patient who lacks the protein and found an in-frame deletion from nucleotide 694 to 879, which corresponds to the entire sequence of exons 8 and 9. This sequence encodes one of two Src homology 3 domains and a part of proline-rich domain in p67-phox and lack of these domains seem to have influenced stability of this protein. To know causative reason for the deletion, we analyzed genomic DNA for p67-phox using two sets of primers that covered exons 8 and 9 with adjacent introns. The DNA fragments from the patient were shown to be same in length as those from control. However, the single-strand conformation-polymorphism analysis of the fragments showed that a patient's specimen that included the splice junction of exon 9 exhibited different mobility from the control. By sequencing of the fragment, a homozygous G to A replacement at position +1 of intron 9 was found to be a sole mutation, which reduced the matching score of the splicing sequence to the consensus calculated according to the formula proposed by Shapiro and Senapathy (Nucleic Acids Res 15:7155, 1987). The reduced matching score at the splice doner site (5' splice site) of intron 9 and the original low matching score at the acceptor site (3' splice site) of intron 7 may explain the skipping of exon 8 and 9, and another predicted mechanism is discussed on the basis of Shapiro and Senapathy's hypothesis.


Subject(s)
Exons/genetics , Granulomatous Disease, Chronic/genetics , Phosphoproteins/genetics , Point Mutation , RNA Splicing/genetics , Adult , Base Sequence , DNA Mutational Analysis , Granulomatous Disease, Chronic/enzymology , Humans , Male , Molecular Sequence Data , Neutrophils/enzymology , Phosphoproteins/deficiency , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational , src Homology Domains
12.
Clin Infect Dis ; 20(5): 1292-7, 1995 May.
Article in English | MEDLINE | ID: mdl-7620013

ABSTRACT

The control of leishmaniasis depends on a knowledge of the magnitude of the disease and of exposure to it. Delayed-type hypersensitivity testing can detect prior exposure to the parasite, but there is little agreement regarding the choice of an antigen for such testing. New and Old World leishmanins were tested in a study of patients with confirmed prior cutaneous leishmaniasis (CL), patients with confirmed prior American visceral leishmaniasis (AVL), and controls from areas in Espírito Santo, Brazil, where leishmaniasis is not endemic. Biobrás antigen (a suspended mixture of Leishmania braziliensis guyanensis, Leishmania mexicana amazonensis, and Leishmania mexicana promastigotes) detected 100% of prior CL infections and thus was superior to the Old World antigen, Leishmania major, which detected only 19% of these infections (P < .00001). Soluble New World antigens of Leishmania chagasi evoked a response in 96% of cases of prior AVL, whereas the Old World counterpart, Leishmania infantum, evoked a response in 71% of cases (P < .042). Testing of family members of patients with prior AVL showed greater utility of the New World leishmanins and suggested subclinical exposure of a large number of healthy people in the hyperendemic region. New World skin-test antigens should be used in future epidemiological studies in the Americas to more accurately determine the extent of exposure.


Subject(s)
Antigens, Protozoan/immunology , Leishmania/immunology , Leishmaniasis/diagnosis , Adolescent , Adult , Aged , Animals , Child , Child, Preschool , Humans , Infant , Middle Aged , Skin Tests
13.
Lancet ; 345(8955): 959-61, 1995 Apr 15.
Article in English | MEDLINE | ID: mdl-7715298

ABSTRACT

Kala-azar, or visceral leishmaniasis, in India is generally assumed to be a result of infection with Leishmania donovani. 15 parasite isolates collected over the past 10 years from patients with classical disease were typed by monoclonal antibodies, isoenzymes, and kDNA analysis. 4 were shown to be L tropica, a species historically associated with cutaneous disease and more recently a mild "visceralising" disease from the Desert Storm experience. The results confirm that L tropica is a co-endemic agent of visceral leishmaniasis in India, and may shed light on the rising frequency of therapeutic unresponsiveness to sodium antimony gluconate, which complicates treatment of this lethal disease.


Subject(s)
Leishmania tropica/isolation & purification , Leishmaniasis, Visceral/parasitology , Adolescent , Adult , Animals , Child , Female , Humans , India/epidemiology , Leishmaniasis, Visceral/drug therapy , Leishmaniasis, Visceral/epidemiology , Male
14.
Am J Med Sci ; 309(4): 229-34, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7900747

ABSTRACT

Cytomegalovirus (CMV) commonly infects both normal and immunocompromised hosts. Although it usually produces an asymptomatic infection to mild illness, CMV has the potential to significantly injure many different organs. Reports of CMV causing pericardial disease, however, are limited and documentation of infection by growth of the virus from tissue or fluid is rare. As part of a prospective trial of subxiphoid pericardial biopsy in 57 adult patients with large pericardial effusions, three culture-proven cases and one serologically confirmed case of CMV pericardial disease were discovered. Subsequently, CMV was grown from the pericardium of an infant with congenital heart disease. A review of the documented cases of CMV pericarditis is provided along with a discussion of the pathogenesis and significance of this perhaps not so uncommon disease.


Subject(s)
Cytomegalovirus Infections/virology , Pericarditis/virology , Adult , Aged , Antibodies, Viral/blood , Cytomegalovirus/immunology , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/immunology , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Infant , Male , Middle Aged , Pericarditis/immunology , Prospective Studies
16.
Blood ; 83(2): 531-6, 1994 Jan 15.
Article in English | MEDLINE | ID: mdl-8286749

ABSTRACT

Chronic granulomatous disease (CGD) is characterized by the failure of phagocytic leukocytes to kill certain bacteria and fungi. This is caused by deficiencies in one of the components of NADPH oxidase, the enzyme in phagocytic leukocytes that generates superoxide. In a rare, autosomal recessive form of CGD, a 67-kD cytosolic component of NADPH oxidase (p67-phox) is missing. Until now, mutations in the gene coding for this protein have not been identified. We now report on a 10-year-old girl with lymph node and liver abscesses who was recognized as an A67(0) CGD patient by lack of NADPH oxidase activity in her granulocytes, a cytosolic defect in a cell-free oxidase system, and lack of immunoreactive material with an antiserum against the p67-phox protein. mRNA for this protein was present in normal amounts in her monocytes. This p67-phox mRNA was reverse-transcribed, and the coding region was amplified by polymerase chain reaction in six overlapping fragments and was sequenced. The patient appeared to be homozygous for a G-233-->A mutation, resulting in a nonconservative amino acid change (78Gly-->Glu). This mutation was also found in the genomic DNA of this patient but not in that of 38 normal donors. Both parents and a sister proved to be carriers of the disease, as deduced from the mutation in only one allele. The carrier state was also manifested by intermediate superoxide production by their intact granulocytes and in the cell-free system.


Subject(s)
Granulomatous Disease, Chronic/enzymology , Granulomatous Disease, Chronic/genetics , Heterozygote , NADH, NADPH Oxidoreductases/deficiency , Amino Acid Sequence , Base Sequence , Child , Female , Humans , Molecular Sequence Data , Mutation , NADH, NADPH Oxidoreductases/genetics , NADPH Oxidases
17.
Ann Surg ; 218(6): 777-82, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8257228

ABSTRACT

OBJECTIVE: This study was designed to determine the cause of large pericardial effusions and evaluate the efficacy of subxiphoid pericardiotomy. SUMMARY BACKGROUND DATA: Despite great advances in the techniques used to diagnose pericardial effusions, much controversy remains concerning their cause and the optimal treatment of these effusions. METHODS: In a prospective consecutive case series, 57 patients underwent a thorough preoperative evaluation followed by a subxiphoid pericardiotomy. All tissue and fluid was exhaustively evaluated. Postoperatively, all patients were followed for a least 1 year. RESULTS: Surgery was performed under local anesthesia in 77% of patients, and the complications of surgery were minimal. Pericardial tissue and fluid established or aided in establishing a diagnosis in 81% of patients. Infection and malignancy were the leading causes; the condition in only 4 patients remained undiagnosed. Follow-up revealed recurrent effusion in nine (16%) patients, but only five (9%) required further surgery. The mortality rate at 30 days was 12%, and at 1 year, it was 37%. Fourteen of the 21 deaths occurred in patients with malignancies. CONCLUSIONS: These data show that the cause of most large pericardial effusions can be determined by a thorough evaluation accompanied by subxiphoid pericardiotomy. In addition, subxiphoid pericardial biopsy and window creation is safe and effective in the treatment of these effusions.


Subject(s)
Biopsy/methods , Pericardial Effusion/diagnosis , Pericardial Effusion/surgery , Pericardiectomy/methods , Pericardium/surgery , Follow-Up Studies , Humans , Pericardial Effusion/complications , Pericardial Effusion/mortality , Prospective Studies , Recurrence , Reoperation , Xiphoid Bone
18.
Blood ; 82(12): 3739-44, 1993 Dec 15.
Article in English | MEDLINE | ID: mdl-7903171

ABSTRACT

The genetic defect in the p67phox-deficient form of chronic granulomatous disease (CGD) follows an autosomal recessive pattern of inheritance. When genomic DNA from normal individuals is digested with HindIII and probed with p67phox cDNA an allelic restriction fragment length polymorphism (RFLP) of 4.0 kb or 2.3 kb is detected. We cloned and characterized the p67phox gene using the cDNA and sequenced the exon/intron boundaries, mapping 16 exons on the 40-kb gene. The polymorphic region was then sequenced to identify the inheritance pattern of amniocentesis-derived fetal cells by genomic amplification. The proband, a 9-year-old female patient with p67phox-deficient CGD, and her phenotypically normal mother are homozygous for the RFLP marker, whereas the father and two brothers are heterozygous. The fetus was shown to be heterozygous as well, showing it had inherited at least one normal p67phox gene from the father and that it was predicted to have a normal phenotype. Cord blood samples at birth showed normal oxidative function. Amplification allows rapid detection of the inheritance pattern for fetal diagnosis in informative families. We report the genomic structure of p67phox and an amplification-based method for detection of the marker on chromosome 1q25, used here for prenatal diagnosis of CGD.


Subject(s)
Chromosomes, Human, Pair 1 , Granulomatous Disease, Chronic/diagnosis , Granulomatous Disease, Chronic/genetics , Phosphoproteins/genetics , Polymorphism, Restriction Fragment Length , Prenatal Diagnosis/methods , Adult , Alleles , Base Sequence , Child , Chromosome Mapping , DNA Primers , Exons , Female , Genes, Recessive , Genetic Carrier Screening , Genetic Markers , Homozygote , Humans , Infant , Male , Molecular Sequence Data , Pedigree , Polymerase Chain Reaction/methods , Pregnancy
19.
Clin Infect Dis ; 17 Suppl 1: S58-62, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8399939

ABSTRACT

Although the pathogenic mycoplasmas usually infect the respiratory and urogenital tracts, these organisms also can cause disease in remote sites. Such infections are difficult to diagnose because of both the fastidious nature of the mycoplasmas and the failure to consider their presence. Pericarditis is an uncommonly diagnosed and rarely confirmed example of invasive mycoplasmal infection. As part of a prospective study of large pericardial effusions, we discovered two cases with Mycoplasma pneumoniae infection. Subsequently, two cases of pericarditis due to Mycoplasma hominis and one due to Ureaplasma urealyticum were diagnosed. For all five patients, cultures of pericardial tissue and/or fluid were positive. In addition, four of the five patients either were immunocompromised or had undergone cardiac surgery previously. Appropriate antibiotic therapy was uniformly effective. We report here our experience with mycoplasmal pericarditis, provide evidence of an invasive pathogenesis for this syndrome, and suggest that pericardial disease caused by these organisms may not be an uncommon finding when sought in an aggressive manner.


Subject(s)
Mycoplasma Infections/etiology , Pericarditis/etiology , Adult , Aged , Doxycycline/therapeutic use , Female , Humans , Male , Middle Aged , Mycoplasma/isolation & purification , Mycoplasma Infections/diagnosis , Mycoplasma Infections/drug therapy , Pericardial Effusion/diagnosis , Pericardial Effusion/drug therapy , Pericardial Effusion/etiology , Pericarditis/diagnosis , Pericarditis/drug therapy
20.
Am J Med ; 95(2): 209-13, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8356985

ABSTRACT

PURPOSE: To determine the effectiveness of the preoperative evaluation and overall diagnostic efficacy of subxiphoid pericardial biopsy with fluid drainage in patients with new, large pericardial effusions. DESIGN: A prospective interventional case series of consecutive patients admitted with new, large pericardial effusions. PATIENTS AND METHODS: Fifty-seven of 75 consecutive patients admitted to a university tertiary-care center and a university-affiliated Veterans Administration Medical Center with new, large pericardial effusions were studied over a 20-month period. Each patient was assessed by a comprehensive preoperative evaluation followed by subxiphoid pericardiotomy. The patients' tissue and fluid samples were studied pathologically and cultured for aerobic and anaerobic bacteria, fungi, mycobacteria, mycoplasmas, and viruses. RESULTS: A diagnosis was made in 53 (93%) patients. The principle diagnoses consisted of malignancy in 13 (23%) patients; viral infection in 8 (14%) patients; radiation-induced inflammation in 8 (14%) patients; collagen-vascular disease in 7 (12%) patients; and uremia in 7 (12%) patients. No diagnosis was made in four (7%) patients. A variety of unexpected organisms were cultured from either pericardial fluid or tissue: cytomegalovirus (three), Mycoplasma pneumoniae (two), herpes simplex virus (one), Mycobacterium avium-intracellulare (one), and Mycobacterium chelonei (one). The pericardial fluid yielded a diagnosis in 15 (26%) patients, 11 of whom had malignant effusions. The examination of pericardial tissue was useful in the diagnosis of 13 (23%) patients, 8 of whom had an infectious agent cultured. Of the 57 patients undergoing surgery, the combined diagnostic yield from both fluid and tissue was 19 patients (33%). CONCLUSIONS: A systematic preoperative evaluation in conjunction with fluid and tissue analysis following subxiphoid pericardiotomy yields a diagnosis in the majority of patients with large pericardial effusions. This approach may also result in the culturing of "unusual" infectious organisms from pericardial tissue and fluid.


Subject(s)
Pericardial Effusion/diagnosis , Pericardial Effusion/etiology , Pericardium/pathology , Biopsy , Follow-Up Studies , Humans , Pericardial Effusion/surgery , Pericardium/microbiology , Preoperative Care , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...